Serum (mean AUC and 95% confidence intervals) | Oral fluid (mean AUC and 95% confidence intervals) | |||||||
---|---|---|---|---|---|---|---|---|
Trial (virus isolate) | qRT-PCR | IgM | IgA | IgG | qRT-PCR | IgM | IgA | IgG |
Trial 1: (Ingelvac® PRRS MLV) | 21.6b | 46.6b | 18.5b | 17.4a | 21.0b | 27.6b | 12.3b | 25.1b |
(18.8-24.5) | (43.1-50.2) | (14.6-22.6) | (15.9-18.9) | (17.0-25.1) | (23.9-31.5) | (7.7-17.0) | (20.6-29.6) | |
Trial 2: (Type 1, D09-012332) | 23.8b | 39.5b | 30.0a | 18.3a | 21.2b | 17.6c | 17.9b | 21.9b |
(21.2-26.6) | (31.1-48.0) | (23.2-36.9) | (16.5-20.2) | (18.1-24.3) | (12.0-23.2) | (10.9-24.9) | (16.7-27.2) | |
Trial 3: (Type 2, MN-184) | 38.1a | 53.7a | 31.6a | 18.4a | 31.6a | 35.4a | 26.2a | 30.1a |
(34.9-41.5) | (48.1-59.3) | (24.7-38.5) | (17.1-19.85) | (28.4-34.9) | (28.6-42.3) | (19.1-33.5) | (25.3-34.9) |